Shortened Activated Partial Thromboplastin Time Is Associated With Acute Ischemic Stroke, Stroke Severity, and Neurological Worsening
The role played by hemostasis in the pathogenesis of ischemic strokes is still controversial. The activated partial thromboplastin time (APTT) measures the time necessary to generate fibrin from initiation of the intrinsic pathway. In the present study, we looked for a possible association of ischem...
Saved in:
Published in | Journal of stroke and cerebrovascular diseases Vol. 24; no. 10; pp. 2270 - 2276 |
---|---|
Main Authors | , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Elsevier Inc
01.10.2015
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The role played by hemostasis in the pathogenesis of ischemic strokes is still controversial. The activated partial thromboplastin time (APTT) measures the time necessary to generate fibrin from initiation of the intrinsic pathway. In the present study, we looked for a possible association of ischemic strokes with the shortened APTT.
The study population consisted of 154 patients with acute ischemic strokes who had been admitted from December 2013 to December 2014 to the Department of Neurology, Chiayi Chang Gung Memorial Hospital, and 71 control subjects with no history of stroke.
In a univariate risk analysis, shortened APTT was associated with an odds ratio (OR) for acute ischemic strokes of up to 1.86 (95% confidence interval [CI], 1.06-3.29, P = .031). In a multivariate analysis using a logistic regression model including age, sex, hypertension, diabetes mellitus, and shortened APTT, shortened APTT was still found to significantly add to the risk of ischemic stroke (OR = 2.12 with 95% CI, 1.13-3.98, P = .020). Shortened APTT was also associated significantly with neurological worsening (OR = 3.72 with 95% CI 1.03-13.5, P = .046). As for stroke severity, shortened APTT was associated with an OR for moderate/severe stroke of up to 3.42 (95% CI, 1.53-7.61, P = .003).
Shortened APTT is a prevalent and independent risk factor for ischemic stroke, stroke severity, and neurological worsening after acute stroke. |
---|---|
AbstractList | The role played by hemostasis in the pathogenesis of ischemic strokes is still controversial. The activated partial thromboplastin time (APTT) measures the time necessary to generate fibrin from initiation of the intrinsic pathway. In the present study, we looked for a possible association of ischemic strokes with the shortened APTT.
The study population consisted of 154 patients with acute ischemic strokes who had been admitted from December 2013 to December 2014 to the Department of Neurology, Chiayi Chang Gung Memorial Hospital, and 71 control subjects with no history of stroke.
In a univariate risk analysis, shortened APTT was associated with an odds ratio (OR) for acute ischemic strokes of up to 1.86 (95% confidence interval [CI], 1.06-3.29, P = .031). In a multivariate analysis using a logistic regression model including age, sex, hypertension, diabetes mellitus, and shortened APTT, shortened APTT was still found to significantly add to the risk of ischemic stroke (OR = 2.12 with 95% CI, 1.13-3.98, P = .020). Shortened APTT was also associated significantly with neurological worsening (OR = 3.72 with 95% CI 1.03-13.5, P = .046). As for stroke severity, shortened APTT was associated with an OR for moderate/severe stroke of up to 3.42 (95% CI, 1.53-7.61, P = .003).
Shortened APTT is a prevalent and independent risk factor for ischemic stroke, stroke severity, and neurological worsening after acute stroke. The role played by hemostasis in the pathogenesis of ischemic strokes is still controversial. The activated partial thromboplastin time (APTT) measures the time necessary to generate fibrin from initiation of the intrinsic pathway. In the present study, we looked for a possible association of ischemic strokes with the shortened APTT. The study population consisted of 154 patients with acute ischemic strokes who had been admitted from December 2013 to December 2014 to the Department of Neurology, Chiayi Chang Gung Memorial Hospital, and 71 control subjects with no history of stroke. In a univariate risk analysis, shortened APTT was associated with an odds ratio (OR) for acute ischemic strokes of up to 1.86 (95% confidence interval [CI], 1.06-3.29, P = .031). In a multivariate analysis using a logistic regression model including age, sex, hypertension, diabetes mellitus, and shortened APTT, shortened APTT was still found to significantly add to the risk of ischemic stroke (OR = 2.12 with 95% CI, 1.13-3.98, P = .020). Shortened APTT was also associated significantly with neurological worsening (OR = 3.72 with 95% CI 1.03-13.5, P = .046). As for stroke severity, shortened APTT was associated with an OR for moderate/severe stroke of up to 3.42 (95% CI, 1.53-7.61, P = .003). Shortened APTT is a prevalent and independent risk factor for ischemic stroke, stroke severity, and neurological worsening after acute stroke. The role played by hemostasis in the pathogenesis of ischemic strokes is still controversial. The activated partial thromboplastin time (APTT) measures the time necessary to generate fibrin from initiation of the intrinsic pathway. In the present study, we looked for a possible association of ischemic strokes with the shortened APTT.BACKGROUNDThe role played by hemostasis in the pathogenesis of ischemic strokes is still controversial. The activated partial thromboplastin time (APTT) measures the time necessary to generate fibrin from initiation of the intrinsic pathway. In the present study, we looked for a possible association of ischemic strokes with the shortened APTT.The study population consisted of 154 patients with acute ischemic strokes who had been admitted from December 2013 to December 2014 to the Department of Neurology, Chiayi Chang Gung Memorial Hospital, and 71 control subjects with no history of stroke.METHODSThe study population consisted of 154 patients with acute ischemic strokes who had been admitted from December 2013 to December 2014 to the Department of Neurology, Chiayi Chang Gung Memorial Hospital, and 71 control subjects with no history of stroke.In a univariate risk analysis, shortened APTT was associated with an odds ratio (OR) for acute ischemic strokes of up to 1.86 (95% confidence interval [CI], 1.06-3.29, P = .031). In a multivariate analysis using a logistic regression model including age, sex, hypertension, diabetes mellitus, and shortened APTT, shortened APTT was still found to significantly add to the risk of ischemic stroke (OR = 2.12 with 95% CI, 1.13-3.98, P = .020). Shortened APTT was also associated significantly with neurological worsening (OR = 3.72 with 95% CI 1.03-13.5, P = .046). As for stroke severity, shortened APTT was associated with an OR for moderate/severe stroke of up to 3.42 (95% CI, 1.53-7.61, P = .003).RESULTSIn a univariate risk analysis, shortened APTT was associated with an odds ratio (OR) for acute ischemic strokes of up to 1.86 (95% confidence interval [CI], 1.06-3.29, P = .031). In a multivariate analysis using a logistic regression model including age, sex, hypertension, diabetes mellitus, and shortened APTT, shortened APTT was still found to significantly add to the risk of ischemic stroke (OR = 2.12 with 95% CI, 1.13-3.98, P = .020). Shortened APTT was also associated significantly with neurological worsening (OR = 3.72 with 95% CI 1.03-13.5, P = .046). As for stroke severity, shortened APTT was associated with an OR for moderate/severe stroke of up to 3.42 (95% CI, 1.53-7.61, P = .003).Shortened APTT is a prevalent and independent risk factor for ischemic stroke, stroke severity, and neurological worsening after acute stroke.CONCLUSIONShortened APTT is a prevalent and independent risk factor for ischemic stroke, stroke severity, and neurological worsening after acute stroke. Background The role played by hemostasis in the pathogenesis of ischemic strokes is still controversial. The activated partial thromboplastin time (APTT) measures the time necessary to generate fibrin from initiation of the intrinsic pathway. In the present study, we looked for a possible association of ischemic strokes with the shortened APTT. Methods The study population consisted of 154 patients with acute ischemic strokes who had been admitted from December 2013 to December 2014 to the Department of Neurology, Chiayi Chang Gung Memorial Hospital, and 71 control subjects with no history of stroke. Results In a univariate risk analysis, shortened APTT was associated with an odds ratio (OR) for acute ischemic strokes of up to 1.86 (95% confidence interval [CI], 1.06-3.29, P = .031). In a multivariate analysis using a logistic regression model including age, sex, hypertension, diabetes mellitus, and shortened APTT, shortened APTT was still found to significantly add to the risk of ischemic stroke (OR = 2.12 with 95% CI, 1.13-3.98, P = .020). Shortened APTT was also associated significantly with neurological worsening (OR = 3.72 with 95% CI 1.03-13.5, P = .046). As for stroke severity, shortened APTT was associated with an OR for moderate/severe stroke of up to 3.42 (95% CI, 1.53-7.61, P = .003). Conclusion Shortened APTT is a prevalent and independent risk factor for ischemic stroke, stroke severity, and neurological worsening after acute stroke. |
Author | Wu, Chih-Ying Pan, Yi-Ting Lin, Chun-Hsien Lee, Meng Huang, Ying-Chih Hsu, Huan-Lin Kuo, Chih-Yu Lin, Ya-Hui Kuo, Ya-Wen Huang, Yen-Chu Lee, Jiann-Der Hsu, Chia-Yu Yang, Hsin-Ta |
Author_xml | – sequence: 1 givenname: Chun-Hsien orcidid: 0000-0003-0942-7492 surname: Lin fullname: Lin, Chun-Hsien organization: Department of Neurology, Chang Gung Memorial Hospital at Chiayi, Taiwan – sequence: 2 givenname: Ya-Wen surname: Kuo fullname: Kuo, Ya-Wen organization: Department of Nursing, Asia University, Taichung, Taiwan – sequence: 3 givenname: Chih-Yu surname: Kuo fullname: Kuo, Chih-Yu organization: Department of Neurology, Chang Gung Memorial Hospital at Chiayi, Taiwan – sequence: 4 givenname: Yen-Chu surname: Huang fullname: Huang, Yen-Chu organization: Department of Neurology, Chang Gung Memorial Hospital at Chiayi, Taiwan – sequence: 5 givenname: Chia-Yu surname: Hsu fullname: Hsu, Chia-Yu organization: Department of Neurology, Chang Gung Memorial Hospital at Chiayi, Taiwan – sequence: 6 givenname: Huan-Lin surname: Hsu fullname: Hsu, Huan-Lin organization: Department of Neurology, Chang Gung Memorial Hospital at Chiayi, Taiwan – sequence: 7 givenname: Ya-Hui surname: Lin fullname: Lin, Ya-Hui organization: Department of Neurology, Chang Gung Memorial Hospital at Chiayi, Taiwan – sequence: 8 givenname: Chih-Ying surname: Wu fullname: Wu, Chih-Ying organization: Department of Neurology, Chang Gung Memorial Hospital at Chiayi, Taiwan – sequence: 9 givenname: Ying-Chih surname: Huang fullname: Huang, Ying-Chih organization: Department of Neurology, Chang Gung Memorial Hospital at Chiayi, Taiwan – sequence: 10 givenname: Meng surname: Lee fullname: Lee, Meng organization: Department of Neurology, Chang Gung Memorial Hospital at Chiayi, Taiwan – sequence: 11 givenname: Hsin-Ta surname: Yang fullname: Yang, Hsin-Ta organization: Department of Neurology, Chang Gung Memorial Hospital at Chiayi, Taiwan – sequence: 12 givenname: Yi-Ting surname: Pan fullname: Pan, Yi-Ting organization: Department of Neurology, Chang Gung Memorial Hospital at Chiayi, Taiwan – sequence: 13 givenname: Jiann-Der surname: Lee fullname: Lee, Jiann-Der email: jdlee540908@gmail.com organization: Department of Neurology, Chang Gung Memorial Hospital at Chiayi, Taiwan |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/26169548$$D View this record in MEDLINE/PubMed |
BookMark | eNqVks-O0zAQhyO0iP0Dr4ByRGgb7Lh2kgtSdwXsogqQWrTcLMeZbKeb2MV2KvUBeG-cbeGwgkNPM5I_fxrNb86TE2MNJMlbSjJKqHi3ztY-OPsAGhzUzm6Vb9BnOaE8IyIjpHyWnFHO8knJKT2JPeH5hBFenCbn3q8JoZSX_EVymgsqKj4tz5Jfi5V1AQw06UwH3KoQu2_KBVRdulw529d20ykf0KRL7CG99enMe6vxkbzDsIofhzA-6BX0qNPF44yXh5ouYAsOw-4yVaZJv8DgbGfvUUf_nXUeDJr7l8nzVnUeXh3qRfL944fl9c1k_vXT7fVsPtG8EmGSl03LNBNTVpMaBBe0KiqmmypnnDUlq9uWKNVOC0abQpQaWF60RcUpY1PeCsIukjd778bZnwP4IHv0GrpOGbCDl7SgZRVpLiL6-oAOdQ-N3DjsldvJP6uLwNUe0M5676D9i1Aix7zkWv4rLznmJYmQMa8ouXki0RhUQGuCU9gdp5rvVRAXuEVw0msEo6FBBzrIxuJxuvdPdLpDM8b2ADvwazs4E6OSVPpcErkYb208NcoJYYz9iILP_xccO81vELz2mg |
CitedBy_id | crossref_primary_10_1371_journal_pone_0240483 crossref_primary_10_1002_epi4_12249 crossref_primary_10_1007_s00415_017_8696_4 crossref_primary_10_1177_1076029616631424 crossref_primary_10_1080_09637486_2016_1268101 crossref_primary_10_2147_CIA_S357639 crossref_primary_10_1111_ijlh_12897 crossref_primary_10_2174_1567202620666221027093103 crossref_primary_10_29121_ijrsm_v7_i11_2020_2 crossref_primary_10_1038_s41598_021_83157_5 crossref_primary_10_1155_2022_1901256 crossref_primary_10_3389_fcvm_2021_769857 crossref_primary_10_1016_j_jstrokecerebrovasdis_2015_10_021 crossref_primary_10_1097_MBC_0000000000000947 crossref_primary_10_3390_life14091158 crossref_primary_10_4081_vl_2024_12592 crossref_primary_10_1007_s00484_020_01868_2 crossref_primary_10_1002_acn3_733 crossref_primary_10_1016_j_bbadis_2017_04_015 crossref_primary_10_2174_0118744400298093240520070257 |
Cites_doi | 10.1161/01.STR.25.11.2220 10.1159/000355685 10.1161/01.CIR.99.14.1780 10.1161/01.CIR.95.3.594 10.1182/blood-2010-03-277079 10.1182/blood.V88.10.3698.bloodjournal88103698 10.1001/jama.1980.03300480018016 10.1055/s-0038-1642511 10.1161/01.CIR.100.7.736 10.1161/01.ATV.17.11.3321 10.1212/WNL.0b013e3182918d38 10.2174/1567202612666150102153447 10.1182/blood-2001-11-0140 10.1111/j.1538-7836.2007.02467.x 10.1016/S0140-6736(95)90166-3 10.1182/blood-2004-03-1042 10.1161/ATVBAHA.107.155952 10.1182/blood.V95.12.3678 10.1160/TH06-12-0719 10.1056/NEJM200003093421004 10.1182/blood-2005-12-023697 10.1161/01.STR.0000126890.63512.41 10.1055/s-0032-1301415 10.1309/G98J-ANA9-RMNC-XLYU 10.1016/S0049-3848(00)00380-7 10.1016/j.jstrokecerebrovasdis.2006.11.002 10.1161/01.STR.27.8.1296 10.2174/1567202610666131202115038 10.1097/00001721-200109000-00011 10.1055/s-0037-1613369 10.1046/j.1538-7836.2003.00459.x 10.1016/j.amjmed.2007.10.025 10.1160/TH11-11-0804 10.1073/pnas.0932632100 |
ContentType | Journal Article |
Copyright | 2015 National Stroke Association National Stroke Association Copyright © 2015 National Stroke Association. Published by Elsevier Inc. All rights reserved. |
Copyright_xml | – notice: 2015 National Stroke Association – notice: National Stroke Association – notice: Copyright © 2015 National Stroke Association. Published by Elsevier Inc. All rights reserved. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1016/j.jstrokecerebrovasdis.2015.06.008 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1532-8511 |
EndPage | 2276 |
ExternalDocumentID | 26169548 10_1016_j_jstrokecerebrovasdis_2015_06_008 S105230571500333X 1_s2_0_S105230571500333X |
Genre | Journal Article |
GrantInformation_xml | – fundername: Chang Gung Memorial Hospital grantid: CMRPG6C0632 |
GroupedDBID | --- --K --M .1- .55 .FO .~1 0R~ 1B1 1P~ 1~. 1~5 4.4 457 4G. 53G 5GY 5VS 7-5 71M 8P~ 9JM AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQQT AAQXK AATTM AAXKI AAXUO AAYWO ABBQC ABFNM ABMAC ABMZM ABTEW ABWVN ABXDB ACDAQ ACIEU ACJTP ACRLP ACRPL ADBBV ADEZE ADMUD ADNMO AEBSH AEIPS AEKER AEVXI AFJKZ AFRHN AFTJW AFXBA AFXIZ AGCQF AGHFR AGQPQ AGUBO AGYEJ AHHHB AIEXJ AIIUN AIKHN AITUG AJRQY AJUYK ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CAG COF CS3 EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA GROUPED_DOAJ HVGLF HZ~ IHE J1W KOM L7B M2W M41 MO0 N9A O-L O9- OAUVE OP~ OZT P-8 P-9 P2P PC. Q38 R2- ROL RPZ SDF SDG SEL SES SEW SNG SNH SPCBC SSH SSZ T5K X7M Z5R ~G- AACTN AFKWA AJOXV AMFUW RIG AAIAV ABLVK ABYKQ AHPSJ AISVY AJBFU EFLBG LCYCR NAHTW AAYXX AGRNS CITATION CGR CUY CVF ECM EIF NPM 7X8 |
ID | FETCH-LOGICAL-c596t-28df3c3643b0be65619793cd92353d83bff0aaf4731d768ce327f79513345f603 |
IEDL.DBID | .~1 |
ISSN | 1052-3057 1532-8511 |
IngestDate | Thu Jul 10 22:58:47 EDT 2025 Wed Feb 19 01:58:41 EST 2025 Thu Apr 24 22:55:22 EDT 2025 Tue Jul 01 00:46:23 EDT 2025 Fri Feb 16 04:41:21 EST 2024 Sun Feb 23 10:19:24 EST 2025 Tue Aug 26 16:55:49 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 10 |
Keywords | ischemic association Stroke risk activated partial thromboplastin time |
Language | English |
License | https://www.elsevier.com/tdm/userlicense/1.0 Copyright © 2015 National Stroke Association. Published by Elsevier Inc. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c596t-28df3c3643b0be65619793cd92353d83bff0aaf4731d768ce327f79513345f603 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0003-0942-7492 |
PMID | 26169548 |
PQID | 1718913356 |
PQPubID | 23479 |
PageCount | 7 |
ParticipantIDs | proquest_miscellaneous_1718913356 pubmed_primary_26169548 crossref_primary_10_1016_j_jstrokecerebrovasdis_2015_06_008 crossref_citationtrail_10_1016_j_jstrokecerebrovasdis_2015_06_008 elsevier_sciencedirect_doi_10_1016_j_jstrokecerebrovasdis_2015_06_008 elsevier_clinicalkeyesjournals_1_s2_0_S105230571500333X elsevier_clinicalkey_doi_10_1016_j_jstrokecerebrovasdis_2015_06_008 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2015-10-01 |
PublicationDateYYYYMMDD | 2015-10-01 |
PublicationDate_xml | – month: 10 year: 2015 text: 2015-10-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Journal of stroke and cerebrovascular diseases |
PublicationTitleAlternate | J Stroke Cerebrovasc Dis |
PublicationYear | 2015 |
Publisher | Elsevier Inc |
Publisher_xml | – name: Elsevier Inc |
References | Ananyeva, Kouiavskaia, Shima (bib1) 2002; 99 Torshin (bib15) 2007 Berge, Friis, Sandset (bib34) 2001; 101 Zakai, Ohira, White (bib35) 2008; 121 Folsom, Rosamond, Shahar (bib20) 1999; 100 Kuo, Lin, Kuo (bib21) 2015; 12 Koster, Blann, Briet (bib5) 1995; 345 White (bib16) 2003; 1 Koster, Rosendaal, Reitsma (bib19) 1994; 71 Toschi, Gallo, Lettino (bib12) 1997; 95 Kvistad, Logallo, Oygarden (bib32) 2013; 36 Doggen, Rosendaal, Meijers (bib8) 2006; 108 Prandoni (bib17) 2007; 5 Madi, Greci, Nawaz (bib25) 2001; 12 Lyden, Brott, Tilley (bib10) 1994; 25 Pinelli, Trivulzio, Rossoni (bib26) 2014; 28 Sandercock, Counsell, Kamal (bib38) 2008 (bib11) 1980; 243 Lee, Hsiao, Lee (bib22) 2012; 11 van Hylckama Vlieg, van der Linden, Bertina (bib6) 2000; 95 Gentile, Vaidyula, Kanamalla (bib31) 2007; 98 Martinez-Sanchez, Fuentes, Martinez-Martinez (bib29) 2013; 80 Hjalmarsson, Manhem, Bokemark (bib30) 2014; 2014 Douxfils, Mullier, Robert (bib37) 2012; 107 Feinberg, Erickson, Bruck (bib33) 1996; 27 Barber, Langhorne, Rumley (bib27) 2004; 35 Gailani, Renne (bib2) 2007; 27 Jiang, Doolittle (bib3) 2003; 100 Smith, Lee, Fowkes (bib14) 1997; 17 Tripodi, Chantarangkul, Martinelli (bib24) 2004; 104 Poort, Rosendaal, Reitsma (bib18) 1996; 88 Korte, Clarke, Lefkowitz (bib9) 2000; 113 Martinelli, Girelli, Lunghi (bib23) 2010; 116 Davidson, Hirt, Lal (bib4) 2003; 89 Harenberg, Erdle, Marx (bib36) 2012; 38 Meijers, Tekelenburg, Bouma (bib7) 2000; 342 Badimon, Lettino, Toschi (bib13) 1999; 99 Barrett, Brott, Brown (bib28) 2007; 16 Smith (10.1016/j.jstrokecerebrovasdis.2015.06.008_bib14) 1997; 17 Poort (10.1016/j.jstrokecerebrovasdis.2015.06.008_bib18) 1996; 88 Hjalmarsson (10.1016/j.jstrokecerebrovasdis.2015.06.008_bib30) 2014; 2014 Koster (10.1016/j.jstrokecerebrovasdis.2015.06.008_bib5) 1995; 345 Douxfils (10.1016/j.jstrokecerebrovasdis.2015.06.008_bib37) 2012; 107 Folsom (10.1016/j.jstrokecerebrovasdis.2015.06.008_bib20) 1999; 100 van Hylckama Vlieg (10.1016/j.jstrokecerebrovasdis.2015.06.008_bib6) 2000; 95 Prandoni (10.1016/j.jstrokecerebrovasdis.2015.06.008_bib17) 2007; 5 Martinelli (10.1016/j.jstrokecerebrovasdis.2015.06.008_bib23) 2010; 116 Barrett (10.1016/j.jstrokecerebrovasdis.2015.06.008_bib28) 2007; 16 Barber (10.1016/j.jstrokecerebrovasdis.2015.06.008_bib27) 2004; 35 Berge (10.1016/j.jstrokecerebrovasdis.2015.06.008_bib34) 2001; 101 Kvistad (10.1016/j.jstrokecerebrovasdis.2015.06.008_bib32) 2013; 36 Torshin (10.1016/j.jstrokecerebrovasdis.2015.06.008_bib15) 2007 Jiang (10.1016/j.jstrokecerebrovasdis.2015.06.008_bib3) 2003; 100 Kuo (10.1016/j.jstrokecerebrovasdis.2015.06.008_bib21) 2015; 12 Sandercock (10.1016/j.jstrokecerebrovasdis.2015.06.008_bib38) 2008 Meijers (10.1016/j.jstrokecerebrovasdis.2015.06.008_bib7) 2000; 342 Madi (10.1016/j.jstrokecerebrovasdis.2015.06.008_bib25) 2001; 12 Gentile (10.1016/j.jstrokecerebrovasdis.2015.06.008_bib31) 2007; 98 (10.1016/j.jstrokecerebrovasdis.2015.06.008_bib11) 1980; 243 Lee (10.1016/j.jstrokecerebrovasdis.2015.06.008_bib22) 2012; 11 White (10.1016/j.jstrokecerebrovasdis.2015.06.008_bib16) 2003; 1 Lyden (10.1016/j.jstrokecerebrovasdis.2015.06.008_bib10) 1994; 25 Koster (10.1016/j.jstrokecerebrovasdis.2015.06.008_bib19) 1994; 71 Badimon (10.1016/j.jstrokecerebrovasdis.2015.06.008_bib13) 1999; 99 Zakai (10.1016/j.jstrokecerebrovasdis.2015.06.008_bib35) 2008; 121 Gailani (10.1016/j.jstrokecerebrovasdis.2015.06.008_bib2) 2007; 27 Pinelli (10.1016/j.jstrokecerebrovasdis.2015.06.008_bib26) 2014; 28 Harenberg (10.1016/j.jstrokecerebrovasdis.2015.06.008_bib36) 2012; 38 Davidson (10.1016/j.jstrokecerebrovasdis.2015.06.008_bib4) 2003; 89 Toschi (10.1016/j.jstrokecerebrovasdis.2015.06.008_bib12) 1997; 95 Korte (10.1016/j.jstrokecerebrovasdis.2015.06.008_bib9) 2000; 113 Feinberg (10.1016/j.jstrokecerebrovasdis.2015.06.008_bib33) 1996; 27 Martinez-Sanchez (10.1016/j.jstrokecerebrovasdis.2015.06.008_bib29) 2013; 80 Doggen (10.1016/j.jstrokecerebrovasdis.2015.06.008_bib8) 2006; 108 Ananyeva (10.1016/j.jstrokecerebrovasdis.2015.06.008_bib1) 2002; 99 Tripodi (10.1016/j.jstrokecerebrovasdis.2015.06.008_bib24) 2004; 104 |
References_xml | – volume: 71 start-page: 719 year: 1994 end-page: 722 ident: bib19 article-title: Factor VII and fibrinogen levels as risk factors for venous thrombosis. A case-control study of plasma levels and DNA polymorphisms—the Leiden Thrombophilia Study (LETS) publication-title: Thromb Haemost – volume: 5 start-page: 270 year: 2007 end-page: 275 ident: bib17 article-title: Venous thromboembolism and atherosclerosis: is there a link? publication-title: J Thromb Haemost – volume: 243 start-page: 2296 year: 1980 end-page: 2297 ident: bib11 article-title: From the NIH: New standards for classification and diagnosis of diabetes publication-title: JAMA – volume: 345 start-page: 152 year: 1995 end-page: 155 ident: bib5 article-title: Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis publication-title: Lancet – volume: 100 start-page: 7527 year: 2003 end-page: 7532 ident: bib3 article-title: The evolution of vertebrate blood coagulation as viewed from a comparison of puffer fish and sea squirt genomes publication-title: Proc Natl Acad Sci U S A – year: 2007 ident: bib15 article-title: Physiology and medicine – volume: 11 start-page: 10 year: 2012 end-page: 15 ident: bib22 article-title: Genetic polymorphism of LDLR (rs688) is associated with primary intracerebral hemorrhage publication-title: Curr Neurovasc Res – start-page: CD000024 year: 2008 ident: bib38 article-title: Anticoagulants for acute ischaemic stroke publication-title: Cochrane Database Syst Rev – volume: 27 start-page: 1296 year: 1996 end-page: 1300 ident: bib33 article-title: Hemostatic markers in acute ischemic stroke. Association with stroke type, severity, and outcome publication-title: Stroke – volume: 95 start-page: 3678 year: 2000 end-page: 3682 ident: bib6 article-title: High levels of factor IX increase the risk of venous thrombosis publication-title: Blood – volume: 89 start-page: 420 year: 2003 end-page: 428 ident: bib4 article-title: Molecular evolution of the vertebrate blood coagulation network publication-title: Thromb Haemost – volume: 121 start-page: 231 year: 2008 end-page: 238 ident: bib35 article-title: Activated partial thromboplastin time and risk of future venous thromboembolism publication-title: Am J Med – volume: 12 start-page: 85 year: 2015 end-page: 90 ident: bib21 article-title: Factor VIII levels are associated with ischemic stroke, stroke subtypes and neurological worsening publication-title: Curr Neurovasc Res – volume: 100 start-page: 736 year: 1999 end-page: 742 ident: bib20 article-title: Prospective study of markers of hemostatic function with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study investigators publication-title: Circulation – volume: 101 start-page: 13 year: 2001 end-page: 21 ident: bib34 article-title: Hemostatic activation in acute ischemic stroke publication-title: Thromb Res – volume: 2014 start-page: 694569 year: 2014 ident: bib30 article-title: The role of prestroke glycemic control on severity and outcome of acute ischemic stroke publication-title: Stroke Res Treat – volume: 108 start-page: 4045 year: 2006 end-page: 4051 ident: bib8 article-title: Levels of intrinsic coagulation factors and the risk of myocardial infarction among men: opposite and synergistic effects of factors XI and XII publication-title: Blood – volume: 35 start-page: 1421 year: 2004 end-page: 1425 ident: bib27 article-title: Hemostatic function and progressing ischemic stroke: D-dimer predicts early clinical progression publication-title: Stroke – volume: 17 start-page: 3321 year: 1997 end-page: 3325 ident: bib14 article-title: Hemostatic factors as predictors of ischemic heart disease and stroke in the Edinburgh artery study publication-title: Arterioscler Thromb Vasc Biol – volume: 16 start-page: 34 year: 2007 end-page: 39 ident: bib28 article-title: Sex differences in stroke severity, symptoms, and deficits after first-ever ischemic stroke publication-title: J Stroke Cerebrovasc Dis – volume: 88 start-page: 3698 year: 1996 end-page: 3703 ident: bib18 article-title: A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis publication-title: Blood – volume: 104 start-page: 3631 year: 2004 end-page: 3634 ident: bib24 article-title: A shortened activated partial thromboplastin time is associated with the risk of venous thromboembolism publication-title: Blood – volume: 1 start-page: 2267 year: 2003 end-page: 2270 ident: bib16 article-title: The partial thromboplastin time: defining an era in coagulation publication-title: J Thromb Haemost – volume: 116 start-page: 5688 year: 2010 end-page: 5697 ident: bib23 article-title: Polymorphisms at LDLR locus may be associated with coronary artery disease through modulation of coagulation factor VIII activity and independently from lipid profile publication-title: Blood – volume: 25 start-page: 2220 year: 1994 end-page: 2226 ident: bib10 article-title: Improved reliability of the NIH stroke scale using video training. NINDS TPA stroke study group publication-title: Stroke – volume: 342 start-page: 696 year: 2000 end-page: 701 ident: bib7 article-title: High levels of coagulation factor XI as a risk factor for venous thrombosis publication-title: N Engl J Med – volume: 80 start-page: 1800 year: 2013 end-page: 1805 ident: bib29 article-title: Treatment with statins and ischemic stroke severity: does the dose matter? publication-title: Neurology – volume: 98 start-page: 1007 year: 2007 end-page: 1013 ident: bib31 article-title: Factor VIIa and tissue factor procoagulant activity in diabetes mellitus after acute ischemic stroke: impact of hyperglycemia publication-title: Thromb Haemost – volume: 95 start-page: 594 year: 1997 end-page: 599 ident: bib12 article-title: Tissue factor modulates the thrombogenicity of human atherosclerotic plaques publication-title: Circulation – volume: 28 start-page: 99 year: 2014 end-page: 104 ident: bib26 article-title: Activated partial thromboplastin time correlates with methoxyhydroxyphenylglycol in acute myocardial infarction patients: therapeutic implications for patients at cardiovascular risk publication-title: In Vivo – volume: 27 start-page: 2507 year: 2007 end-page: 2513 ident: bib2 article-title: Intrinsic pathway of coagulation and arterial thrombosis publication-title: Arterioscler Thromb Vasc Biol – volume: 107 start-page: 985 year: 2012 end-page: 997 ident: bib37 article-title: Impact of dabigatran on a large panel of routine or specific coagulation assays. Laboratory recommendations for monitoring of dabigatran etexilate publication-title: Thromb Haemost – volume: 113 start-page: 123 year: 2000 end-page: 127 ident: bib9 article-title: Short activated partial thromboplastin times are related to increased thrombin generation and an increased risk for thromboembolism publication-title: Am J Clin Pathol – volume: 38 start-page: 178 year: 2012 end-page: 184 ident: bib36 article-title: Determination of rivaroxaban in human plasma samples publication-title: Semin Thromb Hemost – volume: 99 start-page: 1780 year: 1999 end-page: 1787 ident: bib13 article-title: Local inhibition of tissue factor reduces the thrombogenicity of disrupted human atherosclerotic plaques: effects of tissue factor pathway inhibitor on plaque thrombogenicity under flow conditions publication-title: Circulation – volume: 12 start-page: 495 year: 2001 end-page: 499 ident: bib25 article-title: The activated partial thromboplastin time in early diagnosis of myocardial infarction publication-title: Blood Coagul Fibrinolysis – volume: 36 start-page: 351 year: 2013 end-page: 354 ident: bib32 article-title: Elevated admission blood pressure and stroke severity in acute ischemic stroke: the Bergen NORSTROKE study publication-title: Cerebrovasc Dis – volume: 99 start-page: 4475 year: 2002 end-page: 4485 ident: bib1 article-title: Intrinsic pathway of blood coagulation contributes to thrombogenicity of atherosclerotic plaque publication-title: Blood – volume: 25 start-page: 2220 year: 1994 ident: 10.1016/j.jstrokecerebrovasdis.2015.06.008_bib10 article-title: Improved reliability of the NIH stroke scale using video training. NINDS TPA stroke study group publication-title: Stroke doi: 10.1161/01.STR.25.11.2220 – volume: 36 start-page: 351 year: 2013 ident: 10.1016/j.jstrokecerebrovasdis.2015.06.008_bib32 article-title: Elevated admission blood pressure and stroke severity in acute ischemic stroke: the Bergen NORSTROKE study publication-title: Cerebrovasc Dis doi: 10.1159/000355685 – volume: 99 start-page: 1780 year: 1999 ident: 10.1016/j.jstrokecerebrovasdis.2015.06.008_bib13 article-title: Local inhibition of tissue factor reduces the thrombogenicity of disrupted human atherosclerotic plaques: effects of tissue factor pathway inhibitor on plaque thrombogenicity under flow conditions publication-title: Circulation doi: 10.1161/01.CIR.99.14.1780 – volume: 95 start-page: 594 year: 1997 ident: 10.1016/j.jstrokecerebrovasdis.2015.06.008_bib12 article-title: Tissue factor modulates the thrombogenicity of human atherosclerotic plaques publication-title: Circulation doi: 10.1161/01.CIR.95.3.594 – volume: 2014 start-page: 694569 year: 2014 ident: 10.1016/j.jstrokecerebrovasdis.2015.06.008_bib30 article-title: The role of prestroke glycemic control on severity and outcome of acute ischemic stroke publication-title: Stroke Res Treat – volume: 116 start-page: 5688 year: 2010 ident: 10.1016/j.jstrokecerebrovasdis.2015.06.008_bib23 article-title: Polymorphisms at LDLR locus may be associated with coronary artery disease through modulation of coagulation factor VIII activity and independently from lipid profile publication-title: Blood doi: 10.1182/blood-2010-03-277079 – volume: 88 start-page: 3698 year: 1996 ident: 10.1016/j.jstrokecerebrovasdis.2015.06.008_bib18 article-title: A common genetic variation in the 3'-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis publication-title: Blood doi: 10.1182/blood.V88.10.3698.bloodjournal88103698 – volume: 243 start-page: 2296 year: 1980 ident: 10.1016/j.jstrokecerebrovasdis.2015.06.008_bib11 article-title: From the NIH: New standards for classification and diagnosis of diabetes publication-title: JAMA doi: 10.1001/jama.1980.03300480018016 – volume: 71 start-page: 719 year: 1994 ident: 10.1016/j.jstrokecerebrovasdis.2015.06.008_bib19 article-title: Factor VII and fibrinogen levels as risk factors for venous thrombosis. A case-control study of plasma levels and DNA polymorphisms—the Leiden Thrombophilia Study (LETS) publication-title: Thromb Haemost doi: 10.1055/s-0038-1642511 – volume: 100 start-page: 736 year: 1999 ident: 10.1016/j.jstrokecerebrovasdis.2015.06.008_bib20 article-title: Prospective study of markers of hemostatic function with risk of ischemic stroke. The Atherosclerosis Risk in Communities (ARIC) Study investigators publication-title: Circulation doi: 10.1161/01.CIR.100.7.736 – volume: 17 start-page: 3321 year: 1997 ident: 10.1016/j.jstrokecerebrovasdis.2015.06.008_bib14 article-title: Hemostatic factors as predictors of ischemic heart disease and stroke in the Edinburgh artery study publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/01.ATV.17.11.3321 – volume: 80 start-page: 1800 year: 2013 ident: 10.1016/j.jstrokecerebrovasdis.2015.06.008_bib29 article-title: Treatment with statins and ischemic stroke severity: does the dose matter? publication-title: Neurology doi: 10.1212/WNL.0b013e3182918d38 – volume: 12 start-page: 85 year: 2015 ident: 10.1016/j.jstrokecerebrovasdis.2015.06.008_bib21 article-title: Factor VIII levels are associated with ischemic stroke, stroke subtypes and neurological worsening publication-title: Curr Neurovasc Res doi: 10.2174/1567202612666150102153447 – volume: 99 start-page: 4475 year: 2002 ident: 10.1016/j.jstrokecerebrovasdis.2015.06.008_bib1 article-title: Intrinsic pathway of blood coagulation contributes to thrombogenicity of atherosclerotic plaque publication-title: Blood doi: 10.1182/blood-2001-11-0140 – year: 2007 ident: 10.1016/j.jstrokecerebrovasdis.2015.06.008_bib15 – volume: 5 start-page: 270 issue: suppl 1 year: 2007 ident: 10.1016/j.jstrokecerebrovasdis.2015.06.008_bib17 article-title: Venous thromboembolism and atherosclerosis: is there a link? publication-title: J Thromb Haemost doi: 10.1111/j.1538-7836.2007.02467.x – volume: 345 start-page: 152 year: 1995 ident: 10.1016/j.jstrokecerebrovasdis.2015.06.008_bib5 article-title: Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis publication-title: Lancet doi: 10.1016/S0140-6736(95)90166-3 – volume: 104 start-page: 3631 year: 2004 ident: 10.1016/j.jstrokecerebrovasdis.2015.06.008_bib24 article-title: A shortened activated partial thromboplastin time is associated with the risk of venous thromboembolism publication-title: Blood doi: 10.1182/blood-2004-03-1042 – volume: 27 start-page: 2507 year: 2007 ident: 10.1016/j.jstrokecerebrovasdis.2015.06.008_bib2 article-title: Intrinsic pathway of coagulation and arterial thrombosis publication-title: Arterioscler Thromb Vasc Biol doi: 10.1161/ATVBAHA.107.155952 – volume: 95 start-page: 3678 year: 2000 ident: 10.1016/j.jstrokecerebrovasdis.2015.06.008_bib6 article-title: High levels of factor IX increase the risk of venous thrombosis publication-title: Blood doi: 10.1182/blood.V95.12.3678 – volume: 98 start-page: 1007 year: 2007 ident: 10.1016/j.jstrokecerebrovasdis.2015.06.008_bib31 article-title: Factor VIIa and tissue factor procoagulant activity in diabetes mellitus after acute ischemic stroke: impact of hyperglycemia publication-title: Thromb Haemost doi: 10.1160/TH06-12-0719 – start-page: CD000024 issue: 8 year: 2008 ident: 10.1016/j.jstrokecerebrovasdis.2015.06.008_bib38 article-title: Anticoagulants for acute ischaemic stroke publication-title: Cochrane Database Syst Rev – volume: 342 start-page: 696 year: 2000 ident: 10.1016/j.jstrokecerebrovasdis.2015.06.008_bib7 article-title: High levels of coagulation factor XI as a risk factor for venous thrombosis publication-title: N Engl J Med doi: 10.1056/NEJM200003093421004 – volume: 108 start-page: 4045 year: 2006 ident: 10.1016/j.jstrokecerebrovasdis.2015.06.008_bib8 article-title: Levels of intrinsic coagulation factors and the risk of myocardial infarction among men: opposite and synergistic effects of factors XI and XII publication-title: Blood doi: 10.1182/blood-2005-12-023697 – volume: 35 start-page: 1421 year: 2004 ident: 10.1016/j.jstrokecerebrovasdis.2015.06.008_bib27 article-title: Hemostatic function and progressing ischemic stroke: D-dimer predicts early clinical progression publication-title: Stroke doi: 10.1161/01.STR.0000126890.63512.41 – volume: 38 start-page: 178 year: 2012 ident: 10.1016/j.jstrokecerebrovasdis.2015.06.008_bib36 article-title: Determination of rivaroxaban in human plasma samples publication-title: Semin Thromb Hemost doi: 10.1055/s-0032-1301415 – volume: 113 start-page: 123 year: 2000 ident: 10.1016/j.jstrokecerebrovasdis.2015.06.008_bib9 article-title: Short activated partial thromboplastin times are related to increased thrombin generation and an increased risk for thromboembolism publication-title: Am J Clin Pathol doi: 10.1309/G98J-ANA9-RMNC-XLYU – volume: 101 start-page: 13 year: 2001 ident: 10.1016/j.jstrokecerebrovasdis.2015.06.008_bib34 article-title: Hemostatic activation in acute ischemic stroke publication-title: Thromb Res doi: 10.1016/S0049-3848(00)00380-7 – volume: 28 start-page: 99 year: 2014 ident: 10.1016/j.jstrokecerebrovasdis.2015.06.008_bib26 article-title: Activated partial thromboplastin time correlates with methoxyhydroxyphenylglycol in acute myocardial infarction patients: therapeutic implications for patients at cardiovascular risk publication-title: In Vivo – volume: 16 start-page: 34 year: 2007 ident: 10.1016/j.jstrokecerebrovasdis.2015.06.008_bib28 article-title: Sex differences in stroke severity, symptoms, and deficits after first-ever ischemic stroke publication-title: J Stroke Cerebrovasc Dis doi: 10.1016/j.jstrokecerebrovasdis.2006.11.002 – volume: 27 start-page: 1296 year: 1996 ident: 10.1016/j.jstrokecerebrovasdis.2015.06.008_bib33 article-title: Hemostatic markers in acute ischemic stroke. Association with stroke type, severity, and outcome publication-title: Stroke doi: 10.1161/01.STR.27.8.1296 – volume: 11 start-page: 10 year: 2012 ident: 10.1016/j.jstrokecerebrovasdis.2015.06.008_bib22 article-title: Genetic polymorphism of LDLR (rs688) is associated with primary intracerebral hemorrhage publication-title: Curr Neurovasc Res doi: 10.2174/1567202610666131202115038 – volume: 12 start-page: 495 year: 2001 ident: 10.1016/j.jstrokecerebrovasdis.2015.06.008_bib25 article-title: The activated partial thromboplastin time in early diagnosis of myocardial infarction publication-title: Blood Coagul Fibrinolysis doi: 10.1097/00001721-200109000-00011 – volume: 89 start-page: 420 year: 2003 ident: 10.1016/j.jstrokecerebrovasdis.2015.06.008_bib4 article-title: Molecular evolution of the vertebrate blood coagulation network publication-title: Thromb Haemost doi: 10.1055/s-0037-1613369 – volume: 1 start-page: 2267 year: 2003 ident: 10.1016/j.jstrokecerebrovasdis.2015.06.008_bib16 article-title: The partial thromboplastin time: defining an era in coagulation publication-title: J Thromb Haemost doi: 10.1046/j.1538-7836.2003.00459.x – volume: 121 start-page: 231 year: 2008 ident: 10.1016/j.jstrokecerebrovasdis.2015.06.008_bib35 article-title: Activated partial thromboplastin time and risk of future venous thromboembolism publication-title: Am J Med doi: 10.1016/j.amjmed.2007.10.025 – volume: 107 start-page: 985 year: 2012 ident: 10.1016/j.jstrokecerebrovasdis.2015.06.008_bib37 article-title: Impact of dabigatran on a large panel of routine or specific coagulation assays. Laboratory recommendations for monitoring of dabigatran etexilate publication-title: Thromb Haemost doi: 10.1160/TH11-11-0804 – volume: 100 start-page: 7527 year: 2003 ident: 10.1016/j.jstrokecerebrovasdis.2015.06.008_bib3 article-title: The evolution of vertebrate blood coagulation as viewed from a comparison of puffer fish and sea squirt genomes publication-title: Proc Natl Acad Sci U S A doi: 10.1073/pnas.0932632100 |
SSID | ssj0011585 |
Score | 2.1697154 |
Snippet | The role played by hemostasis in the pathogenesis of ischemic strokes is still controversial. The activated partial thromboplastin time (APTT) measures the... Background The role played by hemostasis in the pathogenesis of ischemic strokes is still controversial. The activated partial thromboplastin time (APTT)... |
SourceID | proquest pubmed crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 2270 |
SubjectTerms | activated partial thromboplastin time Adult Aged Aged, 80 and over association Brain Ischemia - complications Cardiovascular Female Humans ischemic Lipoproteins - metabolism Male Middle Aged Nervous System Diseases - etiology Neurology Partial Thromboplastin Time Retrospective Studies risk Stroke Stroke - complications Stroke - etiology Thromboplastin - metabolism Time Factors |
Title | Shortened Activated Partial Thromboplastin Time Is Associated With Acute Ischemic Stroke, Stroke Severity, and Neurological Worsening |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S105230571500333X https://www.clinicalkey.es/playcontent/1-s2.0-S105230571500333X https://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2015.06.008 https://www.ncbi.nlm.nih.gov/pubmed/26169548 https://www.proquest.com/docview/1718913356 |
Volume | 24 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3da9swEBelg7KX0X1n3YoGexr1YluWHbOnEFrSjZZBWpo3IckScbfZwXZe97b_e3eynDGWPQT25C9JlnSn0--k0x0h75JCSq6UAua1oKBY0FnzQoVBpLMiDlWsuMQF_avrdH6bfFry5QGZDWdh0KzSy_5epjtp7d-MfW-O12U5XkRuRZNnAGlCxtgST7AnGXL5hx9bMw8APC4sJyYOMPURef_bxuu-7Zr6q9GmAQUUbT-LEl14R9z59MSQk7snq3-BUTcpXRyTRx5N0mlf4cfkwFRPyNGV3y9_Sn4uVmhMC6KUTrULZAZ3X7B9kOtm1dTfVb0G_NyVFcXDIPSypQPBIOVd2a0g46bDD9q5FqAL15Yzf6ULA2MBkPwZlVVBnasPL03pXd20BpddnpHbi_Ob2TzwgRcCzfO0C-JJYZlmAFZUqAwgviiHYawLAIOcFROmrA2ltEnGogLUFW1YnNksx1AxCbdpyJ6Tw6quzEtCbQpFhFobBbjF8lQVuUYXhFIaySKbjch06GGhvVdyDI7xTQzmZ_diF5UEUkk4m7zJiHzclrHufXTslXs2EFYMp1FBfgqYUvYqJdtVimm9SGhFJNpYhOIvth2R823OPzh_7xq8HbhSgIjAfR9ZmXoDfwb8kQNteDoiL3p23fYTKNAp-vx79Z9qcUIe4lNv7viaHHbNxrwB2NapUzcuT8mD6eXn-fUvTpVLDg |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Li9swEBbbLGx7KX03farQU1kT24rsmJ5C2CXpbkIhWTY3oSfxtrWD7fyE_u-OZDmlND0EerKxPLKsGY2-kUYzCH0cKs6pEAKE14CBYsBmzZQIg0imKg5FLCi3C_rzRTK9GX5Z0_UJmnRnYaxbpdf9rU532to_GfjeHGzzfLCM3IomTQHShISQ9T10aqNT0R46Hc-upov9ZkJEXWZO-35gCc7Qp99uXnd1U5XftNQV2KDW_VPlNop3RF1YT5t18vB89S886ualy0fooQeUeNy2-TE60cUTdDb3W-ZP0c_lxvrTgjbFY-lymcHdV_uLQLXaVOUPUW4BQjd5ge15EDyrccczePM2bzZAuGtsgXTRBfDS_cu5v-KlhuEAYP4c80JhF-3DK1R8W1a1tisvz9DN5cVqMg187oVA0ixpgnikDJEE8IoIhQbQF2UwkqUCPEiJGhFhTMi5GaYkUmCxSE3i1KSZzRYzpCYJyXPUK8pCv0TYJFBFKKUWAF0MTYTKpI1CyLnmJDJpH427HmbSBya3-TG-s84D7Y4d4hKzXGLOLW_UR5_3dWzbMB1HUU86xrLuQCqoUAazylG1pIdq0bXXCjWLWB2zkP0luX10saf8Q_iPbsGHTioZaAm79cMLXe7gywBBMuANTfroRSuu-34CGzqxYf9e_adWvEf3p6v5NbueLa5eowe2pPV-fIN6TbXTbwHFNeKdH6W_AGsNTb8 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Shortened+Activated+Partial+Thromboplastin+Time+Is+Associated+With+Acute+Ischemic+Stroke%2C+Stroke+Severity%2C+and+Neurological+Worsening&rft.jtitle=Journal+of+stroke+and+cerebrovascular+diseases&rft.au=Lin%2C+Chun-Hsien%2C+MD&rft.au=Kuo%2C+Ya-Wen%2C+PhD&rft.au=Kuo%2C+Chih-Yu%2C+MD&rft.au=Huang%2C+Yen-Chu%2C+MD&rft.date=2015-10-01&rft.issn=1052-3057&rft.volume=24&rft.issue=10&rft.spage=2270&rft.epage=2276&rft_id=info:doi/10.1016%2Fj.jstrokecerebrovasdis.2015.06.008&rft.externalDBID=ECK1-s2.0-S105230571500333X&rft.externalDocID=1_s2_0_S105230571500333X |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F10523057%2FS1052305714X0011X%2Fcov150h.gif |